Skip to content

Meet us at COP31Read more

Standard BioTools Inc Sustainability Reports

Standard BioTools Inc. develops, manufactures, and markets proprietary mass cytometry and microfluidics technologies. Its tools provide essential data insights for biomedical research, enabling faster and more effective therapeutic development.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 549300GX8Y96GSB6YP89

FIGI: BBG001T0FDP3

11 reports from 2016 to 2025